Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
該当コードがありません。
から:
次の項目別のソート:
日付受信時刻ニュースソース見出しコード企業名
2024/07/1005 : 58Alliance NewsAlliance NewsIN BRIEF: YouGov Non-Executive Director Mishra buys sharesLSE:YOUYougov Plc
2024/07/1005 : 58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:QSRRestaurant Brands International Inc
2024/07/1005 : 58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:WDAYWorkday Inc
2024/07/1005 : 57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:QSRRestaurant Brands International Inc
2024/07/1005 : 57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:QSRRestaurant Brands International Inc
2024/07/1005 : 57Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CERTCertara Inc
2024/07/1005 : 57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:QSRRestaurant Brands International Inc
2024/07/1005 : 57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALKTAlkami Technology Inc
2024/07/1005 : 57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:QSRRestaurant Brands International Inc
2024/07/1005 : 57Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:RYRoyal Bank of Canada
2024/07/1005 : 57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:QSRRestaurant Brands International Inc
2024/07/1005 : 57Business WireOlson Grimsley Attorneys Named to 2024 Lawdragon 500 X – The Next Generation
2024/07/1005 : 56Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:MS-PMorgan Stanley
2024/07/1005 : 56Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:RYRoyal Bank of Canada
2024/07/1005 : 56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HYZNHyzon Motors Inc
2024/07/1005 : 55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HYZNHyzon Motors Inc
2024/07/1005 : 54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HYZNHyzon Motors Inc
2024/07/1005 : 54Edgar (US Regulatory)Form 8-K - Current reportNYSE:ECC-DEagle Point Credit Company Inc
2024/07/1005 : 54Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsUSOTC:PUCKUGoal Acquisition Corporation (PK)
2024/07/1005 : 54Business WireMicroVention kündigt klinische Veröffentlichung von SOFAST an: SOFIA™ Absaugsystem als Erstlinientechnik bei der Behandlung des akuten ischämischen Schlaganfalls
2024/07/1005 : 54Business WireNorth East Scotland College Selects YuJa Panorama Digital Accessibility Platform to Increase Accessibility for Students Across Six Locations
2024/07/1005 : 54Business WireMicroVention annonce la publication clinique de SOFAST avec le système d'aspiration SOFIA™ comme technique de première intention dans le traitement de l'accident vasculaire cérébral ischémique aigu
2024/07/1005 : 53Edgar (US Regulatory)Form 8-K - Current reportNYSE:DRQDril Quip Inc
2024/07/1005 : 53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:OUSTOuster Inc
2024/07/1005 : 53Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:VCTRVictory Capital Holdings Inc
2024/07/1005 : 53Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:BMOBank of Montreal
2024/07/1005 : 53GlobeNewswire Inc.FDA Approves Arcutis’ ZORYVE® (roflumilast) Cream 0.15% for the Treatment of Atopic Dermatitis in Adults and Children Down to 6 Years of AgeNASDAQ:ARQTArcutis Biotherapeutics Inc
2024/07/1005 : 52Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:HIMSHims and Hers Health Inc
2024/07/1005 : 52Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:JPM-MJP Morgan Chase and Co
2024/07/1005 : 52Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:LGNDLigand Pharmaceuticals Incorporated